Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: A simple method using day 1 CD34+ cell yield

Journal of Clinical Apheresis

Volumn 26, Issue 3, 2011, Pages 111-115

  Duong, Hien K ^a   Bolwell, Brian J ^a   Rybicki, Lisa ^b   Koo, Anna ^a   Hsi, Eric D ^b   Figueroa, Priscilla ^b   Dean, Robert ^a   Pohlman, Brad ^a   Kalaycio, Matt ^a   Andresen, Steven ^a   Sobecks, Ronald ^a   Copelan, Edward ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CD34 cells; multiple myeloma; stem cell mobilization

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LENALIDOMIDE; MELPHALAN; MITOXANTRONE; PLERIXAFOR;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CD34 SELECTION; CONTROLLED STUDY; FEMALE; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION;

ADULT; AGED; ANTIGENS, CD34; BLOOD CELL COUNT; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE;

EID: 80051529827     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20278     Document Type: Article

References (28)

1. Bolwell BJ, Pohlman B, Rybicki L, Sobecks R, Dean R, Curtis J, Andresen S, Koo A, Mineff V, Kalaycio M, Sweetenham JW,. Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies. Bone Marrow Transplant 2007; 40: 437-441. (Pubitemid 47288222)
2. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
3. Jillella AP, Ustun C,. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant? Stem Cells Dev 2004; 13: 598-606. (Pubitemid 40052636)
4. Demirer T, Buckner CD, Bensinger WI,. Optimization of peripheral blood stem cell mobilization. Stem Cells 1996; 14: 106-116. (Pubitemid 26041425)
5. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W,. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
6. Boeve S, Strupeck J, Creech S, Stiff P,. Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use, and cost. Bone Marrow Transplant 2004; 33: 997-1003. (Pubitemid 38744785)
7. Perseghin P, Terruzzi E, Dassi M, Baldini V, Parm M, Coluccia P, Accorsi P, Confalonieri G, Tavecchia L, Verga L, et al. Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions. Transfus Apher Sci 2009; 41: 33-37.
8. Dreger P, Kloss M, Petersen B, Haferlach T, Loffler H, Loeffler M, Schmitz N,. Autologous progenitor cell transplantation: prior exposure to stem cell toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995; 86: 3970-3978.
9. Morris CL, Siegel E, Barlogie B, Cottler-Fox M, Lin P, Fassas A, Zangari M, Anaissie E, Tricot G,. Mobilization of CD34+ cells in elderly patients (≥70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003; 120: 413-423. (Pubitemid 36241497)
10. Krieger MS, Schiller G, Berenson JR, Stewart K, Noga SJ, Ballesters O, Tarantol S, Stiff P, Khun D, Scerzo E, Sing A, et al. Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells. Bone Marrow Transplant 1999; 24: 25-28. (Pubitemid 29346600)
11. Marques JF, Vigorito AC, Aranha FJ, Lorand-Metze I, Miranda ECM, Lima Filho EC, Valbonesi M, Santini G, DeSouza CA,. Early total white blood cell recovery is a predictor of low number of apheresis and good CD34+ cell yield. Transfus Sci 2000; 23: 91-100.
12. Aerts E, Babic A, Devine H, Derache F, Mank A, Schouten H, Worel N,. Haematopoietic stem cell mobilisation and apheresis: a practical guide for nurses and other allied health care professionals. EBMT Educational Booklet 2010; 1-36.
13. Majado MJ, Minguela A, Gonzalez-Garcia C, Salido E, Blanquer M, Funes C, Insausti CL, Garcia-Hernandez AM, Moraleda JM, Morales A,. Large-volume apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients. J Clin Apher 2009; 24: 12-17.
14. Sutherland DR, Anderson L, Keeny M, Nayar R, Chin-Yee I,. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5:213- 226.
15. Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockeri-Goldstein KE, Sempek DS, Smith AL, DiPersio JF,. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant 2008; 14: 1045-1056.
16. Dawson MA, Schwarer AP, Muirhead JL, Bailey MJ, Bollard GM, Spencer A,. Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen. Bone Marrow Transplant 2005; 36: 389-396. (Pubitemid 43115025)
17. Goterris R, Hernandez-Boluda JC, Teruel A, Gomez C, Lis MJ, Terol MJ, Tormo M, Solano C, Arbona C,. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplant 2005; 36: 847-853. (Pubitemid 41655609)
18. Gertz MA, Wolf RC, Micallef INM, Gastineau DA,. Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma. Bone Marrow Transplant 2010; 45 (a): 1396-1403.
19. Stiff PJ,. Management strategies for the hard-to-mobilize patient. Bone Marrow Transplant 1999; 23 (Suppl 2): S29-S33. (Pubitemid 29216708)
20. Sugrue MW, Williams K, Pollock BH, Khan S, Peracha S, Wingard JR, Moreb JS,. Characterization and outcome of "hard to mobilize" lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 2000; 39: 509-519. (Pubitemid 32162390)
21. Gidron A, Singh V, Egan K, Mehta J,. Significance of low peripheral blood CD34+ cell numbers prior to leukopheresis: what should the threshold required for apheresis be? Bone Marrow Transplant 2008; 42: 439-442.
22. Basquiera AL, Abichain P, Damonte JC, Ricchi B, Sturich AG, Palazzo ED, Garcia JJ,. The number of CD34+ cells in peripheral blood as a predictor of CD34+ yield in patients going to autologous stem cell transplantation. J Clin Apher 2006; 21: 92-95.
23. Schlenke P, Frohn C, Hennig H, Weber K, Kisro J, Saballus M, Kirchner H, Kluter H,. Collection efficiencies of CD34+ progenitor cells and mononuclear cells in leukopheresis products quantified by flow cytometry and calculated on the basis of a new formula. Vox Sanguinis 2000; 78: 242-249. (Pubitemid 30481257)
24. Wuchter P, Ran D, Bruckner T, Schmitt T, Witzens-Harig M, Neben K, Goldschmidt H, Ho AD,. Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation. Biol Blood Marrow Transplant 2010; 16: 490-499.
25. Callera F, Cavenaghi L, de Melo C MTP,. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: a feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF. Trans Apher Sci 2009; 40: 91-95.
26. Neumann T, Kruger WH, Busemann C, Kiefer T, Dolken G,. Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone. Bone Marrow Transplant, e-pub ahead of print 2 August 2010.
27. D'Addio A, Curti A, Worel N, Douglas K, Motta MR, Rizzi S, Dan E, Taioli S, Guidice V, Agis H, Kopetzky G, Soutar R, Casadei B, Baccarani M, Lemoli RM,. The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. Bone Marrow Transplant, e-pub ahead of print 31 May 2010.
28. Stiff P, Micallef I, McCarthy P, Magalhaes-Silverman M, Weisdorf D, Territo M, Badel K, Calandra G,. Treatment with Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given the mobilizing regimen of G-CSF: implications for the heavily pre-treated patient. Biol Blood Marrow Transplant 2009; 15: 249-256.